American business magazine Forbes has added three Bangladeshi companies to its “Asia’s 200 Best Under A Billion list”.
The list highlights 200 Asia-Pacific public companies with sales under $1 billion US Dollars (USD). Forbes claims the companies added to the list have” track records of exceptional corporate performance” and “scored above their peers in a composite ranking that includes sales and profit growth, low debt levels and robust governance”
Of the three, the company to post the biggest figures was Square Pharmaceuticals. The list gives the pharmaceutical company a market value of 1,716 million USD, with a sales and net income of 512 and 150 million respectively. Followed closely by Renata pharmaceutical, which the list attributes a market value of 1,071 million, sales 512 million, and a net income of 45 million US Dollars.
Last one on the list, Fortune Shoes reported a market value of 28 million, with sales and figure of 18 million and a net income of 3 million.
